PRESS RELEASE published on 04/23/2026 at 07:30, 3 months 27 days ago OSE Immunotherapeutics annonce la présentation des résultats de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire au Congrès 2026 de l’ASCO OSE Immunotherapeutics annonce la présentation des résultats de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire au Congrès 2026 de l’ASCO. Présentation orale le 30 mai 2026, à Chicago, Etats-Unis Étude De Phase 2 OSE Immunotherapeutics ASCO Cancer De L'ovaire TEDOVA
PRESS RELEASE published on 04/23/2026 at 07:30, 3 months 27 days ago OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting OSE Immunotherapeutics announces topline results from TEDOVA Phase 2 trial of Tedopi® in Ovarian Cancer at ASCO 2026 Meeting. Presentation by lead investigator Alexandra Leary, MD, PhD Ovarian Cancer OSE Immunotherapeutics Tedopi® TEDOVA Phase 2 ASCO 2026
PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Helvetia Baloise successfully places three senior bond tranches totalling CHF 550 million Helvetia Baloise successfully places three senior bond tranches totalling CHF 550 million on Swiss capital market. Proceeds for corporate purposes & potential refinancing. Strong investor demand Investor Demand Swiss Capital Market Helvetia Baloise Senior Bond Tranches CHF 550 Million
PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1% Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026 Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026 with sales revenue up 7.9% in constant currencies. Profitability remains strong with a margin of 30.7% and net profit of 88 million euros Profitability Sartorius Stedim Biotech Sales Revenue First-quarter Results Fiscal 2026
PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Sartorius Stedim Biotech publie de bons résultats pour le premier trimestre de l’exercice 2026 Sartorius Stedim Biotech publie de bons résultats pour le premier trimestre de l'exercice 2026, avec un chiffre d'affaires en hausse de 7,9% à taux de change constant Chiffre D'affaires Croissance EBITDA Sartorius Stedim Biotech Résultat Trimestriel
REGULATED PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago bioMérieux – First-Quarter 2026 Business Review bioMérieux reports -3.9% organic sales decline in Q1 2026 due to weaker respiratory season and geopolitical factors. Revises 2026 guidance. CEO emphasizes innovation and cost control for positive CEBIT evolution Innovation BioMérieux Sales Decline 2026 Guidance CEBIT Evolution
REGULATED PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Safran reports first quarter 2026 revenue Safran reports strong Q1 2026 revenue growth of 18.8%, CEO expresses confidence in full-year outlook, details key division performances and currency hedging strategy Safran Revenue Growth CEO Statement Currency Hedging Q1 2026
REGULATED PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Edenred records sustained growth in Q1 and confirms its objectives for 2026 and beyond Edenred reports +8.2% revenue growth in Q1 2026, maintains objectives for 2026. Receives 'A' rating from CDP for ESG leadership. Amplify25-28 strategic plan execution continues Edenred Revenue Growth Q1 2026 CDP 'A' Rating Amplify25-28
REGULATED PRESS RELEASE published on 04/23/2026 at 07:00, 3 months 27 days ago Safran publie son chiffre d’affaires du 1er trimestre 2026 Safran publie son chiffre d'affaires du 1er trimestre 2026 avec une forte croissance. Perspectives confirmées pour l'année. Communiqué détaillé sur les activités et performances financières Chiffre D'affaires Croissance Safran Performances Financières Trimestre 2026
Published on 08/21/2026 at 02:30, 1 hour 45 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 4 hours 15 minutes ago Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 5 hours 15 minutes ago EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 6 hours 15 minutes ago Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M
Published on 08/20/2026 at 15:30, 12 hours 45 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/21/2026 at 03:05, 1 hour 9 minutes ago From Tokyo to Berlin, VMFi is Transforming the Multilingual Communication Landscape.
Published on 08/21/2026 at 03:00, 1 hour 14 minutes ago 5.096 Million Units Exported in Six Months: Beyond the Headline Figure, China is Reshaping Global Automotive Rules
Published on 08/21/2026 at 02:35, 1 hour 39 minutes ago Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'
Published on 08/20/2026 at 20:32, 7 hours 42 minutes ago EQS-Adhoc: DEAG Deutsche Entertainment Aktiengesellschaft: DEAG is planning a capital increase of EUR 10 million
Published on 08/18/2026 at 18:00, 2 days 10 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 10 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 2 days 16 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 2 days 16 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 3 days 8 hours ago Aéroports de Paris S.A - July 2026 traffic figures